Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

2.69
Delayed Data
As of Jan 16
 -0.11 / -3.93%
Today’s Change
2.20
Today|||52-Week Range
3.94
-5.28%
Year-to-Date

Today’s Trading

Previous close2.80
Today’s open2.80
Day’s range2.65 - 2.85
Volume1,771,703
Average volume (3 months)1,354,552
Market cap$380.8M
Data as of 4:00pm ET, 01/16/2018

Growth & Valuation

Earnings growth (last year)+3.05%
Earnings growth (this year)+24.97%
Earnings growth (next 5 years)--
Revenue growth (last year)+23.83%
P/E ratioNM
Price/Sales52.96
Price/Book1.27

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc-0.37-5.58%
OXFDOxford Immunotec Glo...-0.55-4.51%
QTNTQuotient Ltd+0.07+1.70%
TRIBTrinity Biotech PLC-0.01-0.28%
Data as of 4:00pm ET, 01/16/2018

Financials

Next reporting dateMarch 7, 2018
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$6.8M
Annual profit (last year)-$128.5M
Net profit margin-1,894.05%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
Chief Financial Officer &
Senior Vice President
Sam Martin
Corporate headquarters
Hampton, New Jersey

Forecasts